Feed Preview

Fast Growing

Alzheimer's Disease: Early Markers

Alzheimer's Disease: Early Markers diagram by

Alzheimer's disease is a chronic neurodegenerative disease. This feed focuses on early markers, as well as environmental, pharmacological, and drug-response biomarkers associated with this disease.

Top 20 most recent papers
Nature Communications

The epichaperome is a mediator of toxic hippocampal stress and leads to protein connectivity-based dysfunction

Nature CommunicationsJanuary 18, 2020
Maria Carmen IndaGabriela Chiosis
44
1
Annals of Clinical and Translational Neurology

Circulating ceramide ratios and risk of vascular brain aging and dementia

Annals of Clinical and Translational NeurologyJanuary 18, 2020
Emer R McGrathSudha Seshadri
Journal of Alzheimer's Disease : JAD

CCL23: A Chemokine Associated with Progression from Mild Cognitive Impairment to Alzheimer's Disease

Journal of Alzheimer's Disease : JADJanuary 21, 2020
Júlia FauraJoan Montaner
1
Chest

Respiratory disease and lower pulmonary function as risk factors for dementia: a systematic review with meta-analysis: Pulmonary function and dementia

ChestJanuary 19, 2020
Tom C RussG David Batty
12
Biological Psychiatry

Cyclin-Dependent Kinase 5-Dependent BAG3 Degradation Modulates Synaptic Protein Turnover

Biological PsychiatryJanuary 21, 2020
Jiechao ZhouJie Zhang
1
1
International Journal of Molecular Sciences

NDRG2 Expression Correlates with Neurofibrillary Tangles and Microglial Pathology in the Ageing Brain

International Journal of Molecular SciencesJanuary 18, 2020
Motaz M FadulJulie E Simpson
Alzheimer's Research & Therapy

PET imaging of mGluR5 in Alzheimer's disease

Alzheimer's Research & TherapyJanuary 20, 2020
Adam P MeccaChristopher H van Dyck
3
bioRxiv

Modular slowing of resting-state dynamic Functional Connectivity as a marker of cognitive dysfunction induced by sleep deprivation

bioRxivJanuary 18, 2020
Diego LombardoDemian Battaglia
8
Nature Communications

Functional brain architecture is associated with the rate of tau accumulation in Alzheimer's disease

Nature CommunicationsJanuary 19, 2020
Nicolai FranzmeierAlzheimer’s Disease Neuroimaging Initiative (ADNI)
57
2
European Journal of Nuclear Medicine and Molecular Imaging

Direct prospective comparison of 18 F-FDG PET and arterial spin labelling MR using simultaneous PET/MR in patients referred for diagnosis of dementia

European Journal of Nuclear Medicine and Molecular ImagingJanuary 22, 2020
Jenny CeccariniKoen Van Laere
bioRxiv

Multimodal magnetic resonance imaging predicts regional amyloid-β burden in the brain

bioRxivJanuary 18, 2020
Anusha Alathur RangarajanHoward Aizenstein
3
Journal of Natural Medicines

Accelerative effects of carbazole-type alkaloids from Murraya koenigii on neurite outgrowth and their derivative's in vivo study for spatial memory

Journal of Natural MedicinesJanuary 22, 2020
Mamiko YanoHisashi Matsuda
Human Molecular Genetics

Reduction of Tet2 exacerbates early stage Alzheimer's pathology and cognitive impairments in 2 × Tg-ad mice

Human Molecular GeneticsJanuary 17, 2020
Liping LiQinwen Wang
The Journal of Immunology : Official Journal of the American Association of Immunologists

An Altered Relationship between Soluble TREM2 and Inflammatory Markers in Young Adults with Down Syndrome: A Preliminary Report

The Journal of Immunology : Official Journal of the American Association of ImmunologistsJanuary 22, 2020
Grace E WeberLynn M Bekris
Journal of Alzheimer's Disease : JAD

Reduced Hippocampal Glutamate and Posterior Cingulate N-Acetyl Aspartate in Mild Cognitive Impairment and Alzheimer's Disease Is Associated with Episodic Memory Performance and White Matter Integrity in the Cingulum: A Pilot Study

Journal of Alzheimer's Disease : JADJanuary 21, 2020
Dickson WongRobert Bartha
4
1
Brain and Behavior

Intranasal deferoxamine can improve memory in healthy C57 mice, suggesting a partially non-disease-specific pathway of functional neurologic improvement

Brain and BehaviorJanuary 22, 2020
Jared M FineLeah R Hanson
Journal of Alzheimer's Disease : JAD

Ultra-High Field MRI in Alzheimer's Disease: Effective Transverse Relaxation Rate and Quantitative Susceptibility Mapping of Human Brain In Vivo and Ex Vivo Compared to Histology

Journal of Alzheimer's Disease : JADJanuary 21, 2020
Elisa TuzziGisela E Hagberg
Brain and Behavior

The novel GLP-1/GIP analogue DA5-CH reduces tau phosphorylation and normalizes theta rhythm in the icv. STZ rat model of AD

Brain and BehaviorJanuary 22, 2020
Cheng LiZhiju Wang
Journal of Alzheimer's Disease : JAD

Diagnostic Accuracy of MRI Visual Rating Scales in the Diagnosis of Early Onset Cognitive Impairment

Journal of Alzheimer's Disease : JADJanuary 21, 2020
Neus FalgàsAlbert Lladó
Journal of Alzheimer's Disease : JAD

The Role of Free and Cued Selective Reminding Test in Predicting [18F]Florbetaben PET Results in Mild Cognitive Impairment and Mild Dementia

Journal of Alzheimer's Disease : JADJanuary 21, 2020
Marco SpallazziPaolo Caffarra
9

See more papers from this feed

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

© 2020 Meta ULC. All rights reserved
/feed-previews/alzheimers-disease-early-markers/3f21ed1f-09e4-44f3-b22b-8e0c54be37b6